Asia Pacific Pharmaceutical Contract Sales Organizations Market Forecast to 2030 - Regional Analysis - by Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), and End User (Biopharmaceutical Companies and Pharmaceutical Companies)
The Asia Pacific pharmaceutical contract sales organizations market is expected to grow from US$ 1,707.48 million in 2022 to US$ 3,646.88 million by 2030. It is estimated to record a CAGR of 10.0% from 2022 to 2030.
Rising Use of Telemedicine and Remote Detailing Drives Asia Pacific Pharmaceutical Contract Sales Organizations Market
The increasing use of telemedicine and remote detailing leads to new opportunities for the pharmaceutical contract sales organization (CSO) market. The transformative influence of digital health technologies has redefined patient-doctor interactions and revolutionized the dynamics of pharmaceutical sales. With its capacity to facilitate virtual consultations and engagements, telemedicine creates a fertile ground for CSOs to adapt and innovate. Remote detailing, which involves using digital channels to communicate product information and engage healthcare professionals, becomes a strategic avenue for CSOs to extend their reach. This strategic change highlights the pharmaceutical industry's proactive approach to navigating the market's complexity. By working with CSOs, these businesses can access specialist sales personnel, leveraging outside expertise to increase market penetration and improve sales effectiveness. Through this collaborative model, pharmaceutical companies may streamline their operations and concentrate on key capabilities like research and development while utilizing the specific knowledge of CSOs to increase the marketability of their products. The rising cooperation between pharmaceutical corporations and CSOs demonstrates a dedication to adaptation and a profound grasp of the developing dynamics within the very competitive pharmaceutical industry. It also displays a nuanced understanding of resource optimization. This mutually beneficial partnership makes revenue maximization possible and strategically places pharmaceutical firms in a market where adaptability and focused market strategies are essential for long-term success.
Asia Pacific Pharmaceutical Contract Sales Organizations Market Overview
The Asia Pacific pharmaceutical contract sales organization market has experienced significant growth in recent years owing to the elevated demand for cost-effective sales and marketing solutions. Pharmaceutical companies face the challenge of reaching diverse and remote markets in countries such as China, India, and Japan, despite a significant demand for healthcare products in these countries. By outsourcing sales and marketing functions to CSOs, the companies can benefit from the expertise of specialized teams without the need for extensive infrastructure and personnel investments. Furthermore, the rise in chronic diseases and the growing aging population in the Asia Pacific region have also contributed to the expansion of the pharmaceutical contract sales organization market.
The increasing availability and adoption of digital technologies, and easy access to a large number of data sources allow pharmaceutical CSOs to gather and analyze real-time data, thereby assisting their clients with the use of actionable insights. In April 2023, SANOFI China adopted a scalable, commercial omnipresence CRM solution that would adapt to its evolving, dynamic business model, thereby accelerating digital transformation and allowing the company to continue working toward innovation. Omnipresence CRM uses advanced analytics, data sources, and machine learning to generate insights, support better decision-making, and create new opportunities for commercial teams to speed up results with increased agility.
Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Pharmaceutical Contract Sales Organizations Market Segmentation
The Asia Pacific pharmaceutical contract sales organizations market is segmented into services, modules, therapeutic area, end user, and country.
Based on services, the Asia Pacific pharmaceutical contract sales organizations market is bifurcated into commercial services and non-commercial services. The commercial services segment held a larger share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.
Based on modules, the Asia Pacific pharmaceutical contract sales organizations market is bifurcated into syndicated modules and dedicated modules. The syndicated modules segment held a larger share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.
Based on therapeutic area, the Asia Pacific pharmaceutical contract sales organizations market is segmented into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others. The oncology segment held the largest share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.
Based on end user, the Asia Pacific pharmaceutical contract sales organizations market is bifurcated into biopharmaceutical companies and pharmaceutical companies. The pharmaceutical companies segment held a larger share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.
Based on country, the Asia Pacific pharmaceutical contract sales organizations market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific pharmaceutical contract sales organizations market in 2022.
Aenova Holding GmbH, CMIC Holdings Co Ltd, EPS Holdings Inc, IQVIA Holdings Inc, Mednext Pharmaceuticals Pvt Ltd, Pfizer Inc, and Syneos Health Inc are some of the leading companies operating in the Asia Pacific pharmaceutical contract sales organizations market.
Rising Use of Telemedicine and Remote Detailing Drives Asia Pacific Pharmaceutical Contract Sales Organizations Market
The increasing use of telemedicine and remote detailing leads to new opportunities for the pharmaceutical contract sales organization (CSO) market. The transformative influence of digital health technologies has redefined patient-doctor interactions and revolutionized the dynamics of pharmaceutical sales. With its capacity to facilitate virtual consultations and engagements, telemedicine creates a fertile ground for CSOs to adapt and innovate. Remote detailing, which involves using digital channels to communicate product information and engage healthcare professionals, becomes a strategic avenue for CSOs to extend their reach. This strategic change highlights the pharmaceutical industry's proactive approach to navigating the market's complexity. By working with CSOs, these businesses can access specialist sales personnel, leveraging outside expertise to increase market penetration and improve sales effectiveness. Through this collaborative model, pharmaceutical companies may streamline their operations and concentrate on key capabilities like research and development while utilizing the specific knowledge of CSOs to increase the marketability of their products. The rising cooperation between pharmaceutical corporations and CSOs demonstrates a dedication to adaptation and a profound grasp of the developing dynamics within the very competitive pharmaceutical industry. It also displays a nuanced understanding of resource optimization. This mutually beneficial partnership makes revenue maximization possible and strategically places pharmaceutical firms in a market where adaptability and focused market strategies are essential for long-term success.
Asia Pacific Pharmaceutical Contract Sales Organizations Market Overview
The Asia Pacific pharmaceutical contract sales organization market has experienced significant growth in recent years owing to the elevated demand for cost-effective sales and marketing solutions. Pharmaceutical companies face the challenge of reaching diverse and remote markets in countries such as China, India, and Japan, despite a significant demand for healthcare products in these countries. By outsourcing sales and marketing functions to CSOs, the companies can benefit from the expertise of specialized teams without the need for extensive infrastructure and personnel investments. Furthermore, the rise in chronic diseases and the growing aging population in the Asia Pacific region have also contributed to the expansion of the pharmaceutical contract sales organization market.
The increasing availability and adoption of digital technologies, and easy access to a large number of data sources allow pharmaceutical CSOs to gather and analyze real-time data, thereby assisting their clients with the use of actionable insights. In April 2023, SANOFI China adopted a scalable, commercial omnipresence CRM solution that would adapt to its evolving, dynamic business model, thereby accelerating digital transformation and allowing the company to continue working toward innovation. Omnipresence CRM uses advanced analytics, data sources, and machine learning to generate insights, support better decision-making, and create new opportunities for commercial teams to speed up results with increased agility.
Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Pharmaceutical Contract Sales Organizations Market Segmentation
The Asia Pacific pharmaceutical contract sales organizations market is segmented into services, modules, therapeutic area, end user, and country.
Based on services, the Asia Pacific pharmaceutical contract sales organizations market is bifurcated into commercial services and non-commercial services. The commercial services segment held a larger share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.
Based on modules, the Asia Pacific pharmaceutical contract sales organizations market is bifurcated into syndicated modules and dedicated modules. The syndicated modules segment held a larger share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.
Based on therapeutic area, the Asia Pacific pharmaceutical contract sales organizations market is segmented into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others. The oncology segment held the largest share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.
Based on end user, the Asia Pacific pharmaceutical contract sales organizations market is bifurcated into biopharmaceutical companies and pharmaceutical companies. The pharmaceutical companies segment held a larger share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.
Based on country, the Asia Pacific pharmaceutical contract sales organizations market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific pharmaceutical contract sales organizations market in 2022.
Aenova Holding GmbH, CMIC Holdings Co Ltd, EPS Holdings Inc, IQVIA Holdings Inc, Mednext Pharmaceuticals Pvt Ltd, Pfizer Inc, and Syneos Health Inc are some of the leading companies operating in the Asia Pacific pharmaceutical contract sales organizations market.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ASIA PACIFIC PHARMACEUTICAL CONTRACT SALES ORGANIZATIONS MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific PEST Analysis
5. ASIA PACIFIC PHARMACEUTICAL CONTRACT SALES ORGANIZATIONS MARKET - KEY INDUSTRY DYNAMICS
5.1 Key Market Drivers
5.1.1 Increasing Integration of Digital Technologies
5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products
5.2 Key Market Restraints
5.2.1 Quality Issues Associated with Outsourcing
5.3 Key Market Opportunities
5.3.1 Rising Use of Telemedicine and Remote Detailing
5.4 Key Future Trends
5.4.1 Expansion in Emerging Markets
5.5 Impact Analysis:
6. PHARMACEUTICAL CONTRACT SALES ORGANIZATIONS MARKET - ASIA PACIFIC MARKET ANALYSIS
6.1 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
7. ASIA PACIFIC PHARMACEUTICAL CONTRACT SALES ORGANIZATIONS MARKET - REVENUE AND FORECAST TO 2030 - BY SERVICES
7.1 Overview
7.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
7.3 Commercial Services
7.3.1 Overview
7.3.2 Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Non-Commercial Services
7.4.1 Overview
7.4.2 Non-Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
8. ASIA PACIFIC PHARMACEUTICAL CONTRACT SALES ORGANIZATIONS MARKET - REVENUE AND FORECAST TO 2030 - BY MODULES
8.1 Overview
8.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
8.3 Syndicated Modules
8.3.1 Overview
8.3.2 Syndicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Dedicated Modules
8.4.1 Overview
8.4.2 Dedicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9. ASIA PACIFIC PHARMACEUTICAL CONTRACT SALES ORGANIZATIONS MARKET - REVENUE AND FORECAST TO 2030 - BY THERAPEUTIC AREA
9.1 Overview
9.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
9.3 Cardiovascular Disorders
9.3.1 Overview
9.3.2 Cardiovascular Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Metabolic Disorders
9.5.1 Overview
9.5.2 Metabolic Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Neurology
9.6.1 Overview
9.6.2 Neurology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Orthopaedic Diseases
9.7.1 Overview
9.7.2 Orthopedic Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.8 Infectious Diseases
9.8.1 Overview
9.8.2 Infectious Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
10. ASIA PACIFIC PHARMACEUTICAL CONTRACT SALES ORGANIZATIONS MARKET - REVENUE AND FORECAST TO 2030 - BY END USER
10.1 Overview
10.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Biopharmaceutical Companies
10.3.1 Overview
10.3.2 Biopharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical Companies
10.4.1 Overview
10.4.2 Pharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
11. ASIA PACIFIC PHARMACEUTICAL CONTRACT SALES ORGANIZATIONS MARKET - COUNTRY ANALYSIS
11.1 Asia Pacific
11.1.1.1 Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Country
11.1.1.2 China
11.1.1.2.1 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2.2 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.2.3 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.2.4 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.2.5 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.1.3 Japan
11.1.1.3.1 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.3.2 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.3.3 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.3.4 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.3.5 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.1.4 India
11.1.1.4.1 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.4.2 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.4.3 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.4.4 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.4.5 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.1.5 Australia
11.1.1.5.1 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.5.2 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.5.3 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.5.4 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.5.5 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.1.6 South Korea
11.1.1.6.1 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.6.2 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.6.3 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.6.4 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.6.5 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.1.7 Rest of Asia Pacific
11.1.1.7.1 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.7.2 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.7.3 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.7.4 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.7.5 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
12. PHARMACEUTICAL CONTRACT SALES ORGANIZATIONS MARKET - INDUSTRY LANDSCAPE
12.1 Overview
12.2 Growth Strategies
12.2.1 Overview
13. COMPANY PROFILES
13.1 CMIC Holdings Co Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 EPS Holdings Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 IQVIA Holdings Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Syneos Health Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Mednext Pharmaceuticals Pvt Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Aenova Holding GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.7 Pfizer Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. APPENDIX
14.1 About Us
14.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ASIA PACIFIC PHARMACEUTICAL CONTRACT SALES ORGANIZATIONS MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific PEST Analysis
5. ASIA PACIFIC PHARMACEUTICAL CONTRACT SALES ORGANIZATIONS MARKET - KEY INDUSTRY DYNAMICS
5.1 Key Market Drivers
5.1.1 Increasing Integration of Digital Technologies
5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products
5.2 Key Market Restraints
5.2.1 Quality Issues Associated with Outsourcing
5.3 Key Market Opportunities
5.3.1 Rising Use of Telemedicine and Remote Detailing
5.4 Key Future Trends
5.4.1 Expansion in Emerging Markets
5.5 Impact Analysis:
6. PHARMACEUTICAL CONTRACT SALES ORGANIZATIONS MARKET - ASIA PACIFIC MARKET ANALYSIS
6.1 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
7. ASIA PACIFIC PHARMACEUTICAL CONTRACT SALES ORGANIZATIONS MARKET - REVENUE AND FORECAST TO 2030 - BY SERVICES
7.1 Overview
7.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
7.3 Commercial Services
7.3.1 Overview
7.3.2 Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Non-Commercial Services
7.4.1 Overview
7.4.2 Non-Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
8. ASIA PACIFIC PHARMACEUTICAL CONTRACT SALES ORGANIZATIONS MARKET - REVENUE AND FORECAST TO 2030 - BY MODULES
8.1 Overview
8.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
8.3 Syndicated Modules
8.3.1 Overview
8.3.2 Syndicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Dedicated Modules
8.4.1 Overview
8.4.2 Dedicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9. ASIA PACIFIC PHARMACEUTICAL CONTRACT SALES ORGANIZATIONS MARKET - REVENUE AND FORECAST TO 2030 - BY THERAPEUTIC AREA
9.1 Overview
9.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
9.3 Cardiovascular Disorders
9.3.1 Overview
9.3.2 Cardiovascular Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Metabolic Disorders
9.5.1 Overview
9.5.2 Metabolic Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Neurology
9.6.1 Overview
9.6.2 Neurology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Orthopaedic Diseases
9.7.1 Overview
9.7.2 Orthopedic Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.8 Infectious Diseases
9.8.1 Overview
9.8.2 Infectious Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
10. ASIA PACIFIC PHARMACEUTICAL CONTRACT SALES ORGANIZATIONS MARKET - REVENUE AND FORECAST TO 2030 - BY END USER
10.1 Overview
10.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Biopharmaceutical Companies
10.3.1 Overview
10.3.2 Biopharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical Companies
10.4.1 Overview
10.4.2 Pharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
11. ASIA PACIFIC PHARMACEUTICAL CONTRACT SALES ORGANIZATIONS MARKET - COUNTRY ANALYSIS
11.1 Asia Pacific
11.1.1.1 Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Country
11.1.1.2 China
11.1.1.2.1 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2.2 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.2.3 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.2.4 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.2.5 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.1.3 Japan
11.1.1.3.1 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.3.2 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.3.3 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.3.4 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.3.5 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.1.4 India
11.1.1.4.1 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.4.2 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.4.3 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.4.4 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.4.5 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.1.5 Australia
11.1.1.5.1 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.5.2 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.5.3 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.5.4 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.5.5 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.1.6 South Korea
11.1.1.6.1 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.6.2 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.6.3 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.6.4 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.6.5 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.1.7 Rest of Asia Pacific
11.1.1.7.1 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.7.2 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.7.3 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.7.4 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.7.5 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
12. PHARMACEUTICAL CONTRACT SALES ORGANIZATIONS MARKET - INDUSTRY LANDSCAPE
12.1 Overview
12.2 Growth Strategies
12.2.1 Overview
13. COMPANY PROFILES
13.1 CMIC Holdings Co Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 EPS Holdings Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 IQVIA Holdings Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Syneos Health Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Mednext Pharmaceuticals Pvt Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Aenova Holding GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.7 Pfizer Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. APPENDIX
14.1 About Us
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Pharmaceutical Contract Sales Organizations Market Segmentation
Table 2. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 3. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 4. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 5. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 6. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 7. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 8. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 9. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 10. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 11. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 12. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 13. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 15. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 16. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 17. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 19. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 20. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 21. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 26. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
Table 27. Glossary of Terms, Asia Pacific Pharmaceutical Contract Sales Organizations Market
Table 1. Asia Pacific Pharmaceutical Contract Sales Organizations Market Segmentation
Table 2. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 3. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 4. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 5. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 6. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 7. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 8. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 9. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 10. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 11. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 12. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 13. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 15. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 16. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 17. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 19. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 20. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 21. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 26. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
Table 27. Glossary of Terms, Asia Pacific Pharmaceutical Contract Sales Organizations Market
